Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)
- Author
- LEWITT, Peter A1 2 ; GUTTMAN, M3 ; TETRUD, James W4 ; TUITE, Paul J5 ; MORI, Akihisa6 ; CHAIKIN, Philip7 ; SUSSMAN, Neil M7
[1] Department of Neurology, Henry Ford Hospital, United States
[2] Department of Neurology, Wayne State University School of Medicine, Detroit, MI, United States
[3] Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
[4] The Parkinson Institute, Sunnyvale, CA, United States
[5] Department of Neurology, University of Minnesota, Minneapolis, MN, United States
[6] Kyowa Hakko Kogyo Co., Ltd, Tokyo, Japan
[7] Kyowa Pharmaceutical, Inc, Princeton, NJ, United States
6002-US-005 Study Group - Source
Annals of neurology. 2008, Vol 63, Num 3, pp 295-302, 8 p ; ref : 24 ref
- Publisher
- Willey-Liss, Hoboken
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Essai clinique Etude multicentrique Istradéfylline Maladie de Parkinson Pathologie du système nerveux Récepteur adénosinique A2A Maladie dégénérative Pathologie de l'encéphale Pathologie du système nerveux central Syndrome extrapyramidal
- Keyword (en)
- Clinical trial Multicenter study Istradefylline Parkinson disease Nervous system diseases A2A adenosine receptor Degenerative disease Cerebral disorder Central nervous system disease Extrapyramidal syndrome
- Keyword (es)
- Ensayo clínico Estudio multicéntrico Istradefilina Parkinson enfermedad Sistema nervioso patología Receptor adenosínico A2A Enfermedad degenerativa Encéfalo patología Sistema nervosio central patología Extrapiramidal síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
- Discipline
- Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20217864
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/ana.21315 
https://dx.doi.org/10.1002/ana.21315
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ana.21315\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Annals of neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Ann. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"295\";s:8:\"\u0000*\u0000epage\";s:3:\"302\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0364-5134\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LEWITT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:10:\"GUTTMAN, M\";i:1;s:15:\"TETRUD, James W\";i:2;s:13:\"TUITE, Paul J\";i:3;s:13:\"MORI, Akihisa\";i:4;s:15:\"CHAIKIN, Philip\";i:5;s:15:\"SUSSMAN, Neil M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ANNED3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:8:\"\u0000*\u0000place\";s:7:\"Hoboken\";s:6:\"\u0000*\u0000pub\";s:11:\"Willey-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ana.21315\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Annals of neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Ann. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"295\";s:8:\"\u0000*\u0000epage\";s:3:\"302\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0364-5134\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LEWITT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:10:\"GUTTMAN, M\";i:1;s:15:\"TETRUD, James W\";i:2;s:13:\"TUITE, Paul J\";i:3;s:13:\"MORI, Akihisa\";i:4;s:15:\"CHAIKIN, Philip\";i:5;s:15:\"SUSSMAN, Neil M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ANNED3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:8:\"\u0000*\u0000place\";s:7:\"Hoboken\";s:6:\"\u0000*\u0000pub\";s:11:\"Willey-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ana.21315\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ana.21315\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Annals of neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Ann. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"295\";s:8:\"\u0000*\u0000epage\";s:3:\"302\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0364-5134\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LEWITT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:10:\"GUTTMAN, M\";i:1;s:15:\"TETRUD, James W\";i:2;s:13:\"TUITE, Paul J\";i:3;s:13:\"MORI, Akihisa\";i:4;s:15:\"CHAIKIN, Philip\";i:5;s:15:\"SUSSMAN, Neil M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ANNED3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:8:\"\u0000*\u0000place\";s:7:\"Hoboken\";s:6:\"\u0000*\u0000pub\";s:11:\"Willey-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ana.21315\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Annals of neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Ann. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"295\";s:8:\"\u0000*\u0000epage\";s:3:\"302\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0364-5134\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LEWITT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:10:\"GUTTMAN, M\";i:1;s:15:\"TETRUD, James W\";i:2;s:13:\"TUITE, Paul J\";i:3;s:13:\"MORI, Akihisa\";i:4;s:15:\"CHAIKIN, Philip\";i:5;s:15:\"SUSSMAN, Neil M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ANNED3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:8:\"\u0000*\u0000place\";s:7:\"Hoboken\";s:6:\"\u0000*\u0000pub\";s:11:\"Willey-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ana.21315\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Annals of neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Ann. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"295\";s:8:\"\u0000*\u0000epage\";s:3:\"302\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0364-5134\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"LEWITT\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Peter A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:10:\"GUTTMAN, M\";i:1;s:15:\"TETRUD, James W\";i:2;s:13:\"TUITE, Paul J\";i:3;s:13:\"MORI, Akihisa\";i:4;s:15:\"CHAIKIN, Philip\";i:5;s:15:\"SUSSMAN, Neil M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ANNED3\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:170:\"Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)\";s:8:\"\u0000*\u0000place\";s:7:\"Hoboken\";s:6:\"\u0000*\u0000pub\";s:11:\"Willey-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
